A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...

Newsday Zimbabwe She was speaking in an interview on the sidelines of the ongoing Sadc Joint Meeting of Ministers Responsible for Education in Harare yesterday. THE University of Zimbabwe Clinical ...

The FDA greenlights lenacapavir, a semi-annual injectable that prevents infection in over 96% of cases. From a daily pill for ...

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.